Date: 26th September 2026
Regulatory & Compliance Update
USFDA Inspection Details:
- The United States Food and Drug Administration (USFDA) conducted an inspection at the Company's Goa Formulation facility.
- The facility location is Pilerne, Bardez, Goa.
- The inspection period was from 21st September 2026 to 26th September 2026.
Inspection Outcome:
- The inspection concluded with five (5) observations.
- The nature of the observations is related to procedural enhancements.
Company Response Plan:
- The Company will provide a necessary response to the USFDA.
- The response will be submitted within the stipulated 15-day timeframe.
Other Disclosures:
Not Specified